Pharma Marketing Network

“Health equity” is disappearing from some corporate conversations, but does that mean the work behind it is disappearing too? For pharmaceutical marketers, the answer...

Pharma marketing has never had more sophisticated tools. AI can accelerate content creation, predictive analytics can uncover audience signals, and omnichannel platforms can personalize...

The FDA wants early drug development to move faster. Now pharma companies may need to ask whether their commercial organizations can keep up. On September...

The 2026 Fierce Pharma Marketing Awards did something more interesting than name this year’s standout campaigns. They changed what counts as award-worthy pharma marketing. For...

What if pharmaceutical marketers could recognize the warning signs of therapy abandonment before a patient actually disengages? That possibility is moving closer with predictive...

What if every great moment in a sporting event could trigger something meaningful beyond the scoreboard? AbbVie is testing that idea with Birdies for...

At the 2026 Life Sciences Product Launch Summit, speakers emphasized early evidence generation, payer engagement, and cross-functional planning as foundations for launch readiness.

Shionogi does not have the luxury of a long patient journey with Xocova. The FDA-approved post-exposure prophylaxis is intended to be started as soon...

There is a big difference between translating an ad and making an ad feel as though it belongs to an audience. Cologuard Plus offers...

A new approach to patient identification is beginning to challenge a basic assumption in pharmaceutical marketing: that marketers already know who the patient is....